Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Department of Health and Human Services
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary resear
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
11/22/2024
Closes
2028-01-07
Eligibility
Eligibility
For profit organizations other than small businessesNative American tribal governments (Federally recognized)Others (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCounty governmentsSpecial district governmentsPublic housing authorities/Indian housing authoritiesIndependent school districtsCity or township governmentsNative American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationPublic and State controlled institutions of higher educationSmall businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationState governments
Program
Funding area
Health - HL
Opportunity #
PAR-25-282
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov